Trial Profile
A Phase I/IIa trial of SomaKit TOC in patients with proven gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs).
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Gallium 68-DOTATOC (Primary)
- Indications Neuroendocrine tumours
- Focus Adverse reactions
- 16 Jan 2017 New trial record